Melanie J. Davies
0000-0002-9987-9371
Publication & Citation Trends
Publications
0 total
Effects of semaglutide in obesity‐related heart failure with preserved ejection fraction across the age spectrum: Findings from the STEP‐HFpEF programme
Cited by 0
Semantic Scholar
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial.
Cited by 11
Semantic Scholar
Frailty and Effects of Semaglutide in Obesity-Related HFpEF: Findings From the STEP-HFpEF Program.
Cited by 5
Semantic Scholar
Semaglutide and Exercise Function in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program.
Cited by 1
Semantic Scholar
Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction: The STEP-HFpEF Program. OA
Cited by 41
Semantic Scholar
Sotagliflozin Significantly Reduces CV Death and Heart Failure-related Outcomes in Patients with Type 2 Diabetes, Chronic Kidney Disease, and History of Heart Failure
Cited by 0
Semantic Scholar
Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program. OA
Cited by 61
Semantic Scholar
Research Topics
Diabetes Treatment and Management
(470)
Diabetes Management and Research
(361)
Metabolism, Diabetes, and Cancer
(242)
Diabetes Management and Education
(229)
Diabetes, Cardiovascular Risks, and Lipoproteins
(181)
Affiliations
Royal Australian College of General Practitioners
University of Geneva
Roche (Switzerland)
University of Stirling
Centre College